MOCK Read BC PDF
MOCK Read BC PDF
MOCK Read BC PDF
test
CANDIDATE NUMBER:
LAST NAME:
FIRST NAME:
OTHER NAMES: Passport Photo
PROFESSION:
VENUE:
TEST DATE:
CANDIDATE SIGNATURE
TIME: 45 MINUTES
INSTRUCTIONS TO CANDIDATES:
DO NOT open this Question Paper until you are told to do so.
Answer ALL questions. Marks are NOT deducted for incorrect answers.
Mark your answers on this Question Paper by filling in the circle using a 2B pencil.
Example:
A
B
A
C
www.occupationalenglishtest.org
© Cambridge Boxhill Language Assessment – ABN 51 988 559 414
A inside buildings.
B without supervision.
Intended use
The active wheelchair is propelled manually and should only be used for independent or assisted
transport of a disabled patient with mobility difficulties. In the absence of an assistant, it should only
be operated by patients who are physically and mentally able to do so safely (e.g., to propel
themselves, steer, brake, etc.). Even where restricted to indoor use, the wheelchair is only suitable
for use on level ground and accessible terrain. This active wheelchair needs to be prescribed and fit
to the individual patient’s specific health condition. Any other or incorrect use could lead hazardous
situations to arise.
It may be necessary to screen staff if there is an outbreak of MRSA within a ward or department.
Results will normally be available within three days, although occasionally additional tests need to
be done in the laboratory. Staff found to have MRSA will be given advice by the Department of
Occupational Health regarding treatment. Even minor skin sepsis or skin diseases such as
eczema, psoriasis or dermatitis amongst staff can result in widespread dissemination of
staphylococci. If a ward has an MRSA problem, staff with any of these conditions (colonised or
infected) must contact Occupational Health promptly, so that they can be screened for MRSA
carriage. Small cuts and/or abrasions must always be covered with a waterproof plaster. Staff with
infected lesions must not have direct contact with patients and must contact Occupational Health.
Infection prevention
Infection control measures are intended to protect patients, hospital workers and others in the
healthcare setting. While infection prevention is most commonly associated with preventing HIV
transmission, these procedures also guard against other blood borne pathogens, such as hepatitis B and
C, syphilis and Chagas disease. They should be considered standard practice since an outbreak of
enteric illness can easily occur in a crowded hospital.
Infection prevention depends upon a system of practices in which all blood and bodily fluids, including
cerebrospinal fluid, sputum and semen, are considered to be infectious. All such fluids from all people
are treated with the same degree of caution, so no judgement is required about the potential infectivity
of a particular specimen. Hand washing, the use of barrier protection such as gloves and aprons, the
safe handling and disposal of ‘sharps’ and medical waste and proper disinfection, cleaning and
sterilisation are all part of creating a safe hospital.
A train the patient how to control their condition with the use of an insulin pump
Many patients with diabetes self-medicate using an insulin pump. If you're caring for a hospitalised
patient with an insulin pump, assess their ability to manage self-care while in the hospital. Patients
using pump therapy must possess good diabetes self-management skills. They must also have a
willingness to monitor their blood glucose frequently and record blood glucose readings,
carbohydrate intake, insulin boluses, and exercise. Besides assessing the patient's physical and
mental status, review and record pump-specific information, such as the pump's make and model.
Also assess the type of insulin being delivered and the date when the infusion site was changed
last. Assess the patient's level of consciousness and cognitive status. If the patient doesn't seem
competent to operate the device, notify the healthcare provider and document your findings.
A relatively infrequent.
Pregnant women
Salbutamol has been in widespread use for many years in humans without apparent ill
consequence. However, there are no adequate and well controlled studies in pregnant women and
there is little published evidence of its safety in the early stages of human pregnancy.
Administration of any drug to pregnant women should only be considered if the anticipated benefits
to the expectant woman are greater than any possible risks to the foetus.
During worldwide marketing experience, rare cases of various congenital anomalies, including cleft
palate and limb defects, have been reported in the offspring of patients being treated with
salbutamol. Some of the mothers were taking multiple medications during their pregnancies.
Because no consistent pattern of defects can be discerned, a relationship with salbutamol use
cannot be established.
C to explain which methods are appropriate for dealing with which types of wounds
Debridement is the removal of non-viable tissue from the wound bed to encourage wound healing. Sharp
debridement is a very quick method, but should only be carried out by a competent practitioner, and may
not be appropriate for all patients. Autolytic debridement is often used before other methods of
debridement. Products that can be used to facilitate autolytic debridement include hydrogels,
hydrocolloids, cadexomer iodine and honey. Hydrosurgery systems combine lavage with sharp
debridement and provide a safe and effective technique, which can be used in the ward environment. This
has been shown to precisely target damaged and necrotic tissue and is associated with a reduced
procedure time. Ultrasonic assisted debridement is a relatively painless method of removing non-viable
tissue and has been shown to be effective in reducing bacterial burden, with earlier transition to secondary
procedures. However, these last two methods are potentially expensive and equipment may not always be
available.
Cardiovascular disease (CVD) is the leading cause of death for both men and women in the United
States. According to the American Heart Association (AHA), by the year 2030, the prevalence of
cardiovascular disease in the USA is expected to increase by 9.9%, and the prevalence of both heart
failure and stroke is expected to increase by approximately 25%. Worldwide, it is projected that CVD
will be responsible for over 25 million deaths per year by 2025. And yet, although several risk factors
are non-modifiable (age, male gender, race, and family history), the majority of contributing factors
are amenable to intervention. These include elevated blood pressure, high cholesterol, smoking,
obesity, diet and excess stress. Aspirin taken in low doses among high risk groups is also
recommended for its cardiovascular benefits.
One modifiable behaviour with major therapeutic implications for CVD is inactivity. Inactive or
sedentary behaviour has been associated with numerous health conditions and a review of several
studies has confirmed that prolonged total sedentary time (measured objectively via an
accelerometer) has a particularly adverse relationship with cardiovascular risk factors, disease, and
mortality outcomes. The cardiovascular effects of leisure time physical activity are compelling and well
documented. Adequate physical leisure activities like walking, swimming, cycling, or stair climbing
done regularly have been shown to reduce type 2 diabetes, some cancers, falls, fractures, and
depression. Improvements in physical function and weight management have also been shown, along
with increases in cognitive function, quality of life, and life expectancy.
Several occupational studies have shown adequate physical activity in the workplace also provides
benefits. Seat-bound bus drivers in London experienced more coronary heart disease than mobile
conductors working on the same buses, as do office-based postal workers compared to their
colleagues delivering mail on foot. The AHA recommends that all Americans invest in at least 30
minutes a day of physical activity on most days of the week. In the face of such unambiguous
evidence, however, most healthy adults, apparently by choice it must be assumed, remain
sedentary.
The cardiovascular beneficial effects of regular exercise for patients with a high risk of coronary
disease have also been well documented. Leisure time exercise reduced cardiovascular mortality
during a 16-year follow-up study of men in the high risk category. In the Honolulu Heart Study, elderly
men walking more than 1.5 miles per day similarly reduced their risk of coronary disease. Such
people engaging in regular exercise have also demonstrated other CVD benefits including decreased
rate of strokes and improvement in erectile dysfunction. There is also evidence of an up to 3-year
increase in lifespan in these groups.
Since data indicate that cardiovascular disease begins early in life, physical interventions such as
regular exercise should be started early for optimum effect. The US Department of Health and Human
Services for Young People wisely recommends that high school students achieve a minimum target of
60 minutes of daily exercise. This may be best achieved via a mandated curriculum. Subsequent
transition from high school to college is associated with a steep decline in physical activity. Provision
of convenient and adequate exercise time as well as free or inexpensive college credits for
documented workout periods could potentially enhance participation. Time spent on leisure time
physical activity decreases further with entry into the workforce. Free health club memberships and
paid supervised exercise time could help promote a continuing exercise regimen. Government
sponsored subsidies to employers incorporating such exercise programs can help decrease the
anticipated future cardiovascular disease burden in this population.
General physicians can play an important role in counselling patients and promoting exercise.
Although barriers such as lack of time and patient non-compliance exist, medical reviews support the
effectiveness of physician counselling, both in the short term and long term. The good news is that the
percentage of adults engaging in exercise regimes on the advice of US physicians has increased from
22.6% to 32.4% in the last decade. The empowerment of physicians, with training sessions and
adequate reimbursement for their services, will further increase this percentage and ensure long-term
adherence to such programmes. Given that risk factors for CVD are consistent throughout the world,
reducing its burden will not only improve the quality of life, but will increase the lifespan for millions of
humans worldwide, not to mention saving billions of health-related dollars.
7. In the first paragraph, what point does the writer make about CVD?
8. In the second paragraph, what does the writer say about inactivity?
A Its role in the development of CVD varies greatly from person to person.
B Its level of risk lies mainly in the overall amount of time spent inactive.
C Its true impact has only become known with advances in technology.
B stress the need for more research into health and safety issues.
10. The phrase 'apparently by choice' in the third paragraph suggests the writer
A Its benefits are most dramatic amongst patients with pre-existing conditions.
B It has more significant effects when combined with other behavioural changes.
C Its value in reducing the risks of CVD is restricted to one particular age group.
D It is always possible for a patient to benefit from making such alterations to lifestyle.
12. The writer says 'short- and long-term CVD benefits' derive from
13. The writer supports official exercise guidelines for US high school students because
D they will gain the maximum long-term benefits from such exercise.
14. What does the writer suggest about general physicians promoting exercise?
A Patients are more likely to adopt effective methods under their guidance.
Ted Kaptchuk is a Professor of Medicine at Harvard Medical School. For the last 15 years, he and
fellow researchers have been studying the placebo effect – something that, before the 1990s, was
seen simply as a thorn in medicine’s side. To prove a medicine is effective, pharmaceutical
companies must show not only that their drug has the desired effects, but that the effects are
significantly greater than those of a placebo control group. However, both groups often show healing
results. Kaptchuk’s innovative studies were among the first to study the placebo effect in clinical trials
and tease apart its separate components. He identified such variables as patients’ reporting bias (a
conscious or unconscious desire to please researchers), patients simply responding to doctors’
attention, the different methods of placebo delivery and symptoms subsiding without treatment – the
inevitable trajectory of most chronic ailments.
Kaptchuk’s first randomised clinical drug trial involved 270 participants who were hoping to alleviate
severe arm pain such as carpal tunnel syndrome or tendonitis. Half the subjects were instructed to take
pain-reducing pills while the other half were told they’d be receiving acupuncture treatment. But just two
weeks into the trial, about a third of participants - regardless of whether they’d had pills or acupuncture -
started to complain of terrible side effects. They reported things like extreme fatigue and nightmarish
levels of pain. Curiously though, these side effects were exactly what the researchers had warned
patients about before they started treatment. But more astounding was that the majority of participants -
in other words the remaining two-thirds - reported real relief, particularly those in the acupuncture group.
This seemed amazing, as no-one had ever proved the superior effect of acupuncture over standard
painkillers. But Kaptchuk’s team hadn’t proved it either. The ‘acupuncture’ needles were in fact retractable
shams that never pierced the skin and the painkillers were actually pills made of corn starch. This study
wasn’t aimed at comparing two treatments. It was deliberately designed to compare two fakes.
Kaptchuk’s needle/pill experiment shows that the methods of placebo administration are as important as
the administration itself. It’s a valuable insight for any health professional: patients’ feelings and beliefs
matter, and the ways physicians present treatments to patients can significantly affect their health. This is
the one finding from placebo research that doctors can apply to their practice immediately. Others such
as sham acupuncture, pills or other fake interventions are nowhere near ready for clinical application.
Using placebo in this way requires deceit, which falls foul of several major pillars of medical ethics,
including patient autonomy and informed consent.
But to really change minds in mainstream medicine, researchers have to show biological evidence – a
feat achieved only in the last decade through imaging technology such as positron emission tomography
(PET) scans and functional magnetic resonance imaging (MRI). Kaptchuk’s team has shown with these
technologies that placebo treatments affect the areas of the brain that modulate pain reception. ‘It’s those
advances in “hard science”’, said one of Kaptchuk’s researchers, ‘that have given placebo research a
legitimacy it never enjoyed before’. This new visibility has encouraged not only research funds but also
interest from healthcare organisations and pharmaceutical companies. As private hospitals in the US run
by healthcare companies increasingly reward doctors for maintaining patients’ health (rather than for the
number of procedures they perform), research like Kaptchuk’s becomes increasingly attractive and the
funding follows.
Another biological study showed that patients with a certain variation of a gene linked to the release of
dopamine were more likely to respond to sham acupuncture than patients with a different variation –
findings that could change the way pharmaceutical companies conduct drug trials. Companies spend
millions of dollars and often decades testing drugs; every drug must outperform placebos if it is to be
marketed. If drug companies could preselect people who have a low predisposition for placebo response,
this could seriously reduce the size, cost and duration of clinical trials, bringing cheaper drugs to the
market years earlier than before.
15. The phrase ‘a thorn in medicine’s side’ highlights the way that the placebo effect
16. In the first paragraph, it’s suggested that part of the placebo effect in trials is due to
17. The results of the trial described in the second paragraph suggest that
18. According to the writer, what should health professionals learn from Kaptchuk’s studies?
C They may not work if patients do not know what they are.
20. What does the phrase ‘This new visibility’ refer to?
21. In the fifth paragraph, it is suggested that Kaptchuk’s research may ultimately benefit from
22. According to the final paragraph, it would be advantageous for companies to be able to use
genetic testing to
A understand why some patients don’t respond to a particular drug.
B choose participants for trials who will benefit most from them.